Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 36, Issue 7, 2009, Pages 1365-1370

  García Gómez, Carmen ^a   Nolla, Joan M ^b   Valverde, Josep ^b   Gómez Gerique, Juan A ^c   Castro, María J ^b   Pintó, Xavier ^b  

^a Department of Internal Medicine   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Cholesterol; Glucocorticoids; Lipoproteins; Rheumatoid arthritis

Indexed keywords

ANTILIPEMIC AGENT; ANTIRHEUMATIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; DEFLAZACORT; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; LIPID ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SPAIN;

ADULT; AGED; ANTIRHEUMATIC AGENTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 67650502429     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080928     Document Type: Article

References (37)

1. Carmona L, Villaverde V, Hernández-García C, Ballina J, Grabiel R, Laffon A; EPISER Study Group. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology 2002;41:88-95.
2. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
3. Young A, Koduri G, Batley M, et al; Early Rheumatoid Arthritis Study (ERAS) Group. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 2007;46:350-7.
4. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8-17.
5. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
6. Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
7. Soubrier M, Zerkak D, Dougados M. Indications for lowering LDL cholesterol in rheumatoid arthritis: An unrecognized problem. J Rheumatol 2006;33:1766-9.
8. Park YB, Lee SK, Lee WK, et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999;26:1701-4.
9. Choi HK, Seeger JD. Lipid profiles among US elderly with untreated rheumatoid arthritis - the Third National Health and Nutrition Examination Survey. J Rheumatol 2005;32:2311-6.
10. Park YB, Choi HK, Kim MY, et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002;113:188-93.
11. Dursunoglu D, Evrengül H, Polat B, et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 2005;25:241-5.
12. Wang J, Hu B, Kong L, Cai H, Zhang C. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation. Clin Chim Acta 2008;390:67-71.
13. Cisternas M, Gutiérrez MA, Klaassen J, Acosta AM, Jacobelli S. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol 2002;29:1619-22.
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
16. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
17. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
18. Gomez-Gerique JA, Gutiérrez-Fuentes JA, Montoya MT, et al. Lipid profile of the Spanish population: The DRECE (diet and risk of cardiovascular disease in Spain) study. Med Clin (Barc) 1999;113:730-5.
19. Gutierrez Fuentes JA, Gómez-Gerique J, Gómez de la Cámara A, Angel Rubio M, García Hernández A, Arístegui I. Diet and Cardiovascular Risk in Spain Study (DRECE II). Description of the evolution of cardiovascular profile. Med Clin (Barc) 2000;115:726-9.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Pinto X, Meco JF, Corbella E, et al. Secondary preventive program of atherosclerosis in a university hospital. Results and predictors of clinical course. Med Clin (Barc) 2003;120:768-72.
22. McQueen MJ, Hawken S, Wang X, et al; INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-33.
23. Scanu AM. Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications. Curr Atheroscler Rep 2003;5:106-13.
24. Salazar A, Mañá J, Pintó X, Argimon JM, Hurtado I, Pujol R. Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia. Clin Chim Acta 2002;320:59-64.
25. Garcia-Gomez C, Nolla JM, Valverde J, Narváez J, Corbella E, Pintó X. High HDL-cholesterol levels in women with rheumatoid arthritis treated with low-dose glucocorticoids. Eur J Clin Invest 2008;38:686-92.
26. Spanakis E, Sidiropoulos P, Papadakis J, et al. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol 2006;33:2440-6.
27. Austin MA. Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Curr Atheroscler Rep 2000;2:200-7.
28. Hurt-Camejo E, Paredes S, Masana L, et al. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum 2001;44:2761-7.
29. Khovidhunkit W, Memon RA, Feingold KR, et al. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000;181 Suppl:S462-S472.
30. Ettinger WH Jr, Sun WH, Binkley N, et al. Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys. J Gerontol A Biol Sci Med Sci 1995;50:M137-M140.
31. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007;57:125-32.
32. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
33. Berglund L, Anuurad E. Role of lipoprotein(a) in cardiovascular disease current and future perspectives. J Am Coll Cardiol 2008;52:132-4.
34. Steiner G, Urowitz MB. Lipid profiles in patients with rheumatoid arthritis: Mechanisms and the impact of treatment. Semin Arthritis Rheum 2008 Apr 4. [Epub ahead of print]
35. Aoki K, Kawai S. Glucocorticoid therapy decreases serum lipoprotein(a) concentration in rheumatic diseases. Intern Med 1993;32:382-6.
36. Asanuma Y, Kawai S, Aoshima H, Kaburaki J, Mizushima Y. Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:443-7.
37. Yoo WH. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. J Rheumatol 2004;31:1746-53.